Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ULBI
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 67,302 | $6.81 | $458.3K Buy | Form 4 ↗ |
| May 22, 2026 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 8,700 | $6.33 | $55.1K Buy | Form 4 ↗ |
| May 21, 2026 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 32,876 | $6.13 | $201.5K Buy | Form 4 ↗ |
| May 18, 2026 | Michael Edward Manna President and CEO, Director | ULBI Ultralife Corporation | Buy | 2,000 | $6.47 | $12.9K Buy | Form 4 ↗ |
| Mar 16, 2026 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 53,131 | $6.76 | $359.2K Buy | Form 4 ↗ |
| Mar 13, 2026 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 100,640 | $6.32 | $636.0K Buy | Form 4 ↗ |
| Mar 12, 2026 | Michael Edward Manna President and CEO, Director | ULBI Ultralife Corporation | Buy | 200 | $6.03 | $1,206 Buy | Form 4 ↗ |
| Mar 12, 2026 | Michael Edward Manna President and CEO, Director | ULBI Ultralife Corporation | Buy | 1,800 | $6.01 | $10.8K Buy | Form 4 ↗ |
| Mar 12, 2026 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 33,741 | $5.97 | $201.4K Buy | Form 4 ↗ |
| Dec 16, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 28,588 | $5.70 | $163.0K Buy | Form 4 ↗ |
| Dec 15, 2025 | Janie Goddard Director | ULBI Ultralife Corporation | Buy | 1,739 | $5.75 | $9,999 Buy | Form 4 ↗ |
| Dec 15, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 14,882 | $5.66 | $84.2K Buy | Form 4 ↗ |
| Dec 12, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 9,530 | $5.63 | $53.7K Buy | Form 4 ↗ |
| Nov 24, 2025 | Robert W. Shaw Director | ULBI Ultralife Corporation | Buy | 1,750 | $5.67 | $9,923 Buy | Form 4 ↗ |
| Nov 19, 2025 | Michael Edward Manna President and CEO, Director | ULBI Ultralife Corporation | Buy | 1,000 | $4.99 | $4,990 Buy | Form 4 ↗ |
| Nov 19, 2025 | Michael Edward Manna President and CEO, Director | ULBI Ultralife Corporation | Buy | 1,000 | $4.94 | $4,940 Buy | Form 4 ↗ |
| Nov 19, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 53,900 | $4.97 | $267.9K Buy | Form 4 ↗ |
| Aug 21, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 29,766 | $6.63 | $197.3K Buy | Form 4 ↗ |
| Aug 20, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 13,000 | $6.57 | $85.4K Buy | Form 4 ↗ |
| Aug 19, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 15,898 | $6.56 | $104.3K Buy | Form 4 ↗ |
| Jun 13, 2025 | Janie Goddard Director | ULBI Ultralife Corporation | Buy | 1,548 | $7.68 | $11.9K Buy | Form 4 ↗ |
| Jun 13, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 10,000 | $7.64 | $76.4K Buy | Form 4 ↗ |
| May 23, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 11,980 | $5.41 | $64.8K Buy | Form 4 ↗ |
| May 15, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 2,140 | $5.72 | $12.2K Buy | Form 4 ↗ |
| May 14, 2025 | Thomas Louis Saeli Director | ULBI Ultralife Corporation | Buy | 5,000 | $5.44 | $27.2K Buy | Form 4 ↗ |
| May 14, 2025 | Robert W. Shaw Director | ULBI Ultralife Corporation | Buy | 4,000 | $5.49 | $22.0K Buy | Form 4 ↗ |
| May 14, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 16,063 | $5.47 | $87.9K Buy | Form 4 ↗ |
| May 13, 2025 | Michael Edward Manna President and CEO, Director | ULBI Ultralife Corporation | Buy | 3,000 | $5.29 | $15.9K Buy | Form 4 ↗ |
| May 13, 2025 | Bradford T. Whitmore Director, 10% owner | ULBI Ultralife Corporation | Buy | 8,957 | $5.40 | $48.4K Buy | Form 4 ↗ |
| Nov 21, 2024 | Michael Edward Manna President and CEO, Director | ULBI Ultralife Corporation | Buy | 1,500 | $7.25 | $10.9K Buy | Form 4 ↗ |
| Nov 12, 2024 | Robert W. Shaw Director | ULBI Ultralife Corporation | Buy | 2,500 | $7.91 | $19.8K Buy | Form 4 ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances